𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation

✍ Scribed by Bo Dupont; Katharine C Hsu


Book ID
104014356
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
471 KB
Volume
16
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis


Identification of inhibitory killer Ig-like receptor (KIR) genes and their cognate human leukocyte antigen (HLA) class I ligands in donor-recipient pairs for patients undergoing haematopoietic stem cell transplantation (HCT) as treatment for haematopoietic malignancies has recently gained considerable interest. One incentive for these studies is to identify potential donors who are not HLA identical with the recipient but who still could serve as acceptable and potentially preferred donors based on their KIR genotype. It is demonstrated that a majority of individuals have at least one inhibitory KIR gene for which they lack the cognate HLA class I ligand. Therefore, the clinical benefits conferred by 'missing KIR ligand' might not be limited only to HLA mismatched donor-recipient combinations but may be applicable also to HLA identical transplants and even autologous HCT.


πŸ“œ SIMILAR VOLUMES


Killer cell immunoglobulin-like receptor
✍ Alejandro Espadas de Arias; Simone Elizabeth Haworth; Luca Saverio Belli; Patriz πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

In 20% to 30% of infected individuals, hepatitis C virus (HCV) can cause cirrhosis and hepatocellular carcinoma, for which liver transplantation is the best treatment available. HCV re-infection is universal, and hepatitis disease recurrence occurs in most cases with a 30% probability of progression